Related Experiment Video

Updated: May 24, 2026

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH
07:13

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH

Published on: April 20, 2021

Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk

Chia-Chi Wang1, Tai-Chung Tseng, Tsung-Cheng Hsieh

  • 1Department of Hepatology, Buddhist Tzu Chi General Hospital, Taipei Branch and School of Medicine, Tzu Chi University, Hualien, Taiwan.

The Kaohsiung Journal of Medical Sciences
|March 6, 2012
PubMed

Insights

The severity of fatty liver disease, as seen on ultrasound, correlates with increased risks of diabetes, metabolic syndrome, and cardiovascular disease. This finding aids in clinical risk stratification for these conditions.

Area of Science:

  • Hepatology
  • Cardiology
  • Endocrinology

Background:

  • Non-alcoholic fatty liver disease (NAFLD) is linked to metabolic and cardiovascular risks.
  • The correlation between ultrasound-assessed NAFLD severity and these risks is not well-defined.

Purpose of the Study:

  • To investigate if the severity of fatty liver on ultrasound correlates with metabolic and cardiovascular disease risk.
  • To assess the utility of ultrasound-based fatty liver grading for risk stratification.

Main Methods:

  • 1000 individuals undergoing health examinations were screened; 874 were analyzed after exclusions.
  • Fatty liver severity was assessed using ultrasound; significant fatty liver was defined as moderate to severe.
  • Metabolic syndrome, diabetes mellitus, and cardiovascular disease risk (Framingham risk score) were evaluated.

Main Results:

  • Increased odds ratios for diabetes mellitus, metabolic syndrome, and cardiovascular disease risk were observed with increasing fatty liver severity in both genders (p ≤ 0.001).
  • Significant differences in risk were found not only between fatty liver and non-fatty liver groups but also between mild and significant fatty liver categories (p < 0.05).

Conclusions:

  • Ultrasound-assessed fatty liver severity is a valuable tool for stratifying patients at risk for metabolic syndrome, diabetes mellitus, and cardiovascular disease.
  • Grading NAFLD severity via ultrasound can inform clinical practice for proactive risk management.

More Related Videos

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...